Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting
Authors
Keywords
Nephrectomy, Sunitinib, Pazopanib, Prognosis, Survival
Journal
WORLD JOURNAL OF UROLOGY
Volume 36, Issue 3, Pages 417-425
Publisher
Springer Nature
Online
2017-12-18
DOI
10.1007/s00345-017-2154-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered
- (2017) Grant D. Stewart et al. EUROPEAN UROLOGY
- Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma
- (2017) Thomas Seisen et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
- (2017) Oscar Rodriguez Faba et al. WORLD JOURNAL OF UROLOGY
- Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis
- (2016) Fausto Petrelli et al. Clinical Genitourinary Cancer
- Sensitivity Analysis Without Assumptions
- (2016) Peng Ding et al. EPIDEMIOLOGY
- Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study
- (2016) Nawar Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based Registry
- (2016) Saskia de Groot et al. UROLOGY
- Systemic therapy in metastatic renal cell carcinoma
- (2016) Jens Bedke et al. WORLD JOURNAL OF UROLOGY
- Second-line treatment for metastatic clear cell renal cell cancer: experts’ consensus algorithms
- (2016) C. Rothermundt et al. WORLD JOURNAL OF UROLOGY
- Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy
- (2016) Allard Noe et al. WORLD JOURNAL OF UROLOGY
- Perioperative outcomes of cytoreductive nephrectomy in the UK in 2012
- (2015) Benjamin L. Jackson et al. BJU INTERNATIONAL
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
- (2014) Daniel Y.C. Heng et al. EUROPEAN UROLOGY
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started